From L-R: Dr Naveen Rao, Rockefeller Foundation; Bj√∂rn K√ľmmel, Federal Ministry of Health, Germany; Dr Sarah Hersy, WHO; Dr Chikwe Ihekweazu, WHO; Prof Leo Yee Sin, National Centre for Infectious Diseases; Singapore; Dr Mario Moreira, President, Fiocruz, Brazil; Dr Josefina Campos, ANLIS Malbr√°n, Argentina.; Dr Alexander Pym, Wellcome Trust; Dame Jenny Harries, Chief Executive, UK Health Security Agency; Prof Tulio de Oliveira, CERI/KRISP, South Africa; Dr Jean Kaseya, Director-General, Africa CDC
WHO and partners are launching a global network to help protect people from infectious disease threats through the power of pathogen genomics. The International Pathogen Surveillance Network (IPSN) will provide a platform to connect countries and regions, improving systems for collecting and analyzing samples, using these data to drive public health decision-making, and sharing that information more broadly.
Pathogen genomics analyzes the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. With this information, scientists and public health officials can identify and track diseases to prevent and respond to outbreaks as part of a broader disease surveillance system, and to develop treatments and vaccines.
The IPSN, with a Secretariat hosted by the WHO Hub for Pandemic and Epidemic Intelligence, brings together experts worldwide at the cutting-edge of genomics and data analytics, from governments, philanthropic foundations, multilateral organizations, civil society, academia and the private sector. All share a common goal: to detect and respond to disease threats before they become epidemics and pandemics, and to optimize routine disease surveillance.
The goal of this new network is ambitious, but it can also play a vital role in health security: to give every country access to pathogen genomic sequencing and analytics as part of its public health system,¬Ē said WHO Director-General Dr Tedros Adhanom Ghebreyesus.¬† ¬ďAs was so clearly demonstrated to us during the COVID-19 pandemic, the world is stronger when it stands together to fight shared health threats.¬Ē
COVID-19 highlighted the critical role pathogen genomics plays in responding to pandemic threats. Without the rapid sequencing of the SARS-COV-2 genome, vaccines would not have been as effective, or have been made available so quickly. New, more transmissible variants of the virus would not have been as quickly identified. Genomics lies at the heart of effective epidemic and pandemic preparedness and response, as well as part of the ongoing surveillance of a vast range of diseases, from foodborne diseases and influenza to tuberculosis and HIV. Its use in monitoring the spread of HIV drug resistance, for example, has led to antiretroviral regimes that have saved countless lives.
News date: 2023-05-20
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).